ArticleBlood advances2025

An ethical allocation scheme for scarce gene therapies in sickle cell disease and transfusion-dependent β-thalassemia.

Amar H Kelkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.